Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiron Acquiring PathoGenesis For Six Times Consensus 2001 Revenues

Executive Summary

Chiron will pay about 6.1 times PathoGenesis' consensus 2001 revenues when it acquires the company for approximately $700 mil. cash.

You may also be interested in...



Ilex Resembles Recent Biotech Acquisition Targets As Campath Nears Market

Ilex Oncology appears to fit the profile of recently acquired companies within the biotechnology industry.

Ilex Resembles Recent Biotech Acquisition Targets As Campath Nears Market

Ilex Oncology appears to fit the profile of recently acquired companies within the biotechnology industry.

Aventis Pasteur MSD Adds Chiron's Meng C and Flu Vaccines To Portfolio

Aventis Pasteur MSD will sell Chiron's meningococcal C vaccine Menjugate and adjuvanted influenza vaccine Fluad under a co-marketing agreement.

UsernamePublicRestriction

Register

MT125529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel